gila monster glp 1 discovery monster: meet the lizard whose venomous bite is saving lives We wouldn't have Ozempic without

While GLP-1 RAs induce weight loss in diabetes, their metabolic impact in normoglycaemic PD patients appears limited

Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases

The internet is buzzing with claims about the ZVOEVO SMGT-GLP-1 Nano Microneedle Patch, hailed as a revolutionary way to manage blood sugar and lose

Learn the science

However, the coexistence of micro and macrovascular disease is associated with the highest cardiovascular risks which highlights the importance that pharmacological treatment of type 2 diabetes mellitus provides not only glycemic control, but also cardiovascular safety

Patent-pending XOSM Technology boosts formula performance with encapsulated antioxidants ectoin, vitamin C and astaxanthin-rich micro-algae while protecting and nourishing skins barrier, for a visibly firm and radiant, younger-looking complexion